SCHEMBL1080038

SCHEMBL1080038

N[C@@H]1CCC[C@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8236493 1.00
SCHEMBL1224698 1.00
SCHEMBL1353564 1.00
SCHEMBL19774666 1.00
SCHEMBL63567 1.00
Hydrochloric Acid SCHEMBL2984413 0.96 THRB (0.35)
Hydrochloric Acid SCHEMBL2984418 0.96 THRB (0.35)
Hydrochloric Acid SCHEMBL14737067 0.96
Hydrochloric Acid SCHEMBL5429301 0.96 THRB (0.35)
SCHEMBL23347490 0.93 THRB (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256451-A1 DISCRIMINATION OF CIS- AND TRANS-1,3-DIAMINOCYCLOHEXANES BASF SE (DE) 2019-08-22 US claimed
EP-2763990-B1 PYRROLOPYRAZINE KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2017-02-22 EP claimed
US-8658646-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LAROCHE INC. (US) 2014-02-25 US claimed
EP-4709720-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2026-03-18 EP disclosed
US-12357631-B2 Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replication COCRYSTAL PHARMA, INC. (US) 2025-07-15 US disclosed
EP-3829719-B1 PYRROLO[2,3-B]PYRIDIN DERIVATIVES AS INHIBITORS OF INFLUENZA VIRUS REPLICATION COCRYSTAL PHARMA INC (US) 2025-04-02 EP disclosed
US-20240383914-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE JANSSEN PHARMACEUTICA NV (BE) 2024-11-21 US disclosed
WO-2024233846-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES, INC. (US) 2024-11-14 WO disclosed
US-12065446-B2 Inhibitors of Bruton's tyrosine kinase and method of their use JANSSEN PHARMACEUTICA NV (BE) 2024-08-20 US disclosed
US-20240217964-A1 QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS NEWAVE PHARMACEUTICAL INC. 2024-07-04 US disclosed
CN-112638477-B Pyrrolo [2,3-B ] pyridine derivatives as inhibitors of influenza virus replication 共晶制药公司 2024-01-26 CN disclosed
US-20050154199-A1 Bridged macrocyclic module compositions COVALENT PARTNERS LLC 2005-07-14 US disclosed
EP-1528924-A1 MCH1R ANTAGONISTS Astrazeneca AB (SE) 2005-05-11 EP disclosed
WO-2005030711-A2 BRIDGED MACROCYCLIC MODULE COMPOSITIONS COVALENT PARTNERS LLC (US) 2005-04-07 WO disclosed
WO-2004004726-A1 MCHIR ANTAGONISTS ASTRAZENECA AB (SE) 2004-01-15 WO disclosed
EP-0765313-B1 N,N'-BIS(QUINOLIN-4-YL)-DIAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMALARIALS HOFFMANN LA ROCHE (CH) 2003-08-20 EP disclosed
EP-0780340-B1 Intercalates and exfoliates formed with functional monomeric organic compounds; composite materials containing same and methods of modifying rheology therewith AMCOL INTERNATIONAL CORP (US) 2002-03-20 EP disclosed
US-5736557-A MICROBIOCIDE EFFECTIVE AGAINST CHLOROQUINE-RESISTANT AND CHLOROQUINE-SENSITIVE STRAINS OF PLASMODIUM FALCIPARUM HOFFMAN-LA ROCHE, INC. (US) 1998-04-07 US disclosed
EP-0765313-A1 N,N'-BIS(QUINOLIN-4-YL)-DIAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMALARIALS F. HOFFMANN-LA ROCHE AG (CH) 1997-04-02 EP disclosed
WO-1995035287-A1 N,N'-BIS(QUINOLIN-4-YL)-DIAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMALARIALS F.HOFFMANN-LA ROCHE AG (CH) 1995-12-28 WO disclosed